$1.85
-0.005[-0.27%]
At close: Apr 25
$1.85
0[0.00%]
After Hours: 9:21AM EDT
GlycoMimetics
(NASDAQ:GLYC)GlycoMimetics Stock (NASDAQ:GLYC), Analyst Ratings, Price Targets, Predictions
GlycoMimetics Inc has a consensus price target of $8, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Capital One, and HC Wainwright & Co. on March 27, 2024, December 22, 2023, and August 3, 2023. With an average price target of $9.33 between HC Wainwright & Co., Capital One, and HC Wainwright & Co., there's an implied 404.50% upside for GlycoMimetics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Capital One
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for GlycoMimetics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/27/2024 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | $8 → $8 | Maintains | Buy | Get Alert |
| 12/22/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 548.65% | Capital One | Zegbeh Jallah | → $12 | Initiates | → Overweight | Get Alert |
| 08/03/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/15/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 05/04/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 02/16/2023 | GLYC | Buy Now | GlycoMimetics | $1.85 | 332.43% | HC Wainwright & Co. | Edward White | $13 → $8 | Maintains | Buy | Get Alert |
| 08/04/2022 | GLYC | Buy Now | GlycoMimetics | $1.85 | 602.7% | HC Wainwright & Co. | Edward White | $14 → $13 | Maintains | Buy | Get Alert |
| 11/12/2021 | GLYC | Buy Now | GlycoMimetics | $1.85 | 116.22% | Jefferies | Roger Song | — | Upgrade | Hold → Buy | Get Alert |
FAQ
What is the target price for GlycoMimetics (GLYC)?
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on March 27, 2024. The analyst firm set a price target for $8.00 expecting GLYC to rise to within 12 months (a possible 332.43% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GlycoMimetics (GLYC)?
The latest analyst rating for GlycoMimetics (NASDAQ: GLYC) was provided by HC Wainwright & Co., and GlycoMimetics maintained their buy rating.
When was the last upgrade for GlycoMimetics (GLYC)?
The last upgrade for GlycoMimetics Inc happened on November 12, 2021 when Jefferies raised their price target to $4. Jefferies previously had a hold for GlycoMimetics Inc.
When was the last downgrade for GlycoMimetics (GLYC)?
There is no last downgrade for GlycoMimetics.
When is the next analyst rating going to be posted or updated for GlycoMimetics (GLYC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on March 27, 2024 so you should expect the next rating to be made available sometime around March 27, 2025.
Is the Analyst Rating GlycoMimetics (GLYC) correct?
While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a maintained with a price target of $8.00 to $8.00. The current price GlycoMimetics (GLYC) is trading at is $1.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.